<DOC>
	<DOC>NCT01343160</DOC>
	<brief_summary>Generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the endoscopic and percutaneous treatment of benign biliary strictures.</brief_summary>
	<brief_title>Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures</brief_title>
	<detailed_description>Primary outcome measure is patency at each follow up visit.</detailed_description>
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>Subject is diagnosed with treatable benign biliary stricture which necessitates the need for implantation of a biliary endoprosthesis Subject is ≥18 years of age Subject is able to comply with study protocol and followup requirements Written informed consent is obtained using the Investigational Review Board (IRB)/Ethics Committee (EC) approved consent form Subject anatomy ruling out covered self expanding metal stent use (e.g. above hilar region) Treatment of stricture would require placement of a covered biliary endoprosthesis within a previously placed bare metal stent The subject has malignant biliary disease Subject has known pregnancy Participated in protocol involving investigational drug or device within 90 days prior to entry into this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>